Blumenberg, V., Birocchi, F., Shih, A., Escobar, G., Mucci, A., Armstrong, A., Cirstea, D., Harris, D. L., Bozym, D., Puliafito, B., Newcomb, R., Dhawale, T., Johnson, P. C., El-Jawahri, A., Jeffrey, R., Barselau, A., Li, A., Emmanuel-Alejandro, E., Cook, D., Lindell, K., Luk, S., Chaffee, R., Yee, A., Branagan, A., Raje, N., Graham, C., Hammond, S., Bushman, F., Doto, A., Reddy, S., McFarland, A., Chen, Y., Mount, C., Dougan, M., Nardi, V., Sohani, A., Gallagher, K. M., Maus, M., Frigault, M., Leick, M. (2025). Ruxolitinib for refractory immune effector cell enterocolitis following ciltacabtagene autoleucel CAR T-cell therapy for multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2392